Phathom Pharmaceuticals, Inc. - COM (PHAT)

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
52 M
Holdings value Q1 2024
$552 M
Value change Q1 2024
+$59.4 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
109
Number of buys Q1 2024
49
Number of sells Q1 2024
-48
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
0%
CUSIP
71722W107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 52 M $552 M +$59.4 M $10.62 109
2023 Q4 46.4 M $424 M +$10.9 M $9.13 112
2023 Q3 43.8 M $453 M +$5.27 M $10.37 110
2023 Q2 42.8 M $613 M +$176 M $14.32 102
2023 Q1 30.8 M $220 M +$28.3 M $7.14 81
2022 Q4 28.2 M $317 M -$21.7 M $11.22 82
2022 Q3 30.1 M $333 M +$38.5 M $11.08 85
2022 Q2 26.9 M $227 M +$9.1 M $8.44 82
2022 Q1 25.5 M $347 M -$61.3 M $13.61 73
2021 Q4 28.4 M $559 M +$47.8 M $19.67 77
2021 Q3 25.4 M $817 M +$19.1 M $32.10 78
2021 Q2 24.9 M $841 M +$13.2 M $33.85 75
2021 Q1 24.5 M $919 M +$1.76 M $37.56 82
2020 Q4 24.5 M $815 M +$96.3 M $33.22 75
2020 Q3 21.6 M $794 M -$7.64 M $36.67 56
2020 Q2 21.8 M $719 M -$3.05 M $32.91 59
2020 Q1 21.9 M $566 M +$3.22 M $25.82 44
2019 Q4 21.8 M $677 M +$593 M $31.14 40